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Abstract
Background: Rare conditions can be catastrophic for families and the implications for public health can be substantial.
Our study compared basic surveillance through active medical record review with a linked administrative data
file to assess the number of cases of two rare conditions, fragile X syndrome (FXS) and muscular dystrophy
(MD) in a population.
Methods: Two methods of data collection were used to collect information from five counties comprising two
standard metropolitan statistical areas of South Carolina. The passive system relied mostly on health claims data
using ICD-9 CM diagnostic codes. The active system relied on a nurse abstracting records from a list of all
licensed physicians with specialties in neurology, orthopedics, and genetics.
Results: There were 141 FXS cases and 348 MD cases that met the case definitions using active surveillance.
Additional cases were found for both conditions but they were determined to not be true cases. After linking
the actively collected MD and FXS cases to passive datasets, we found that the estimated total numbers of
cases were similar to using capture-recapture analysis; the positive predictive values for cases identified in the
passive system were 56.6% for MD and 75.7% for FXS.
Conclusions: Applying capture-recapture methods to passively collected surveillance data for rare health conditions
produced an estimate of the number of true cases that was similar to that obtained through active data collection.
Keywords: Capture-recapture, Muscular dystrophy, Fragile X syndrome, Passive surveillance

Background
There are many rare conditions that first manifest symptoms in childhood and persist into adulthood. It is often
difficult to effectively and efficiently estimate the number of cases of these rare conditions in a specific area.
Some methods, such as reportable condition registries,
may require legislation or other state-level policy, while
methods such as medical record abstraction are costly
and time-intensive. It is our intention to demonstrate a
methodology that uses administrative data to document
rare conditions, when resources are not available to
conduct active case finding. This paper uses two rare
conditions that primarily manifest in males, muscular
* Correspondence: smithmg1@etsu.edu
1
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dystrophy (MD) and Fragile X syndrome (FXS), to test
an algorithm that applies capture-recapture methods to
linked administrative datasets in order to estimate the
number of cases of each condition receiving care in a
five county area of South Carolina. The reported prevalence in the literature is approximately 1/4,000 males for
FXS to 1/5,000 males for MD [1–3].
The expectation that linked administrative records, or
passive surveillance systems, are reliable sources for estimating the true prevalence for health conditions, has
been questioned by many public health professionals
and policy makers [4]. Clearly the low cost of passive
surveillance is attractive, if the data are reasonably accurate. Concerns that have been raised include anticipated inaccuracy associated with imprecision of codes
used in both clinical billing and public agency data.
Thus, active surveillance, which includes professional
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review of records to validate case status, is preferred
when sufficient funding is available. However, despite
reservations about the accuracy of passive surveillance,
when resources are limited, the use of administrative
and claims data has been a longstanding practice [5–7].
Passive surveillance may be particularly useful for rare
conditions, where the resource demands for establishing
effective active surveillance systems may be very large in
relation to the number of cases identified.
There is limited research on the validity of passive surveillance compared to active surveillance (professional
record review). One study compared active chart review
with a hospital database found that inter-database agreement rates varied from relatively high agreement for
common conditions such as diabetes (k = 0.83), good
agreement for myocardial infarction and chronic renal
failure (k = 0.52-0.62), and low agreement for symptoms
such as hyperlipidemia [8] The validity of passive
surveillance approaches for rare conditions has not yet
been established.
An important issue related to passive surveillance is
deciding on a case definition. When conditions are rare
and estimates of prevalence are wanted some researchers
have accepted one code in the primary or secondary
diagnosis field among people who were enrolled in the
insurance plan for a minimum of two years [9]. One of
the strategies used to improve the accuracy of use of
medical insurance claims is to use all the fields for diagnoses and the coding from multiple visits [10–12]. Another strategy is to require at least two records from
each source to define a case [13, 14]. Other algorithms
for case identification require coding for diagnostic testing or treatment, or at least one hospitalization with the
code [15]. Others have required a linkage with a second
administrative data source to verify a disability [6].
In our study of two rare conditions we used a linked
administrative data file that included billing data from a
number of insurers as well as data from agencies that
provided services for people with disability. All cases in
the population may not be covered by one of these insurance providers or receive services from the agencies
included in the passive dataset, therefore a capturerecapture algorithm was used to estimate the total number of cases. The primary objective of this study was to
determine whether data from multiple passive sources
could be used to accurately estimate the number of individuals with rare, lifelong conditions that frequently
onset in childhood using capture-recapture methods.
Therefore, an estimated number of people with FXS and
MD was calculated from passive data sources and compared to the number of cases obtained through active
data collection. Additionally, the active and passive datasets were linked to examine how well these autonomous
systems identified the same individuals as cases. It is not
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expected that capture-recapture methods will aid in
identifying the correct individual cases, but, instead
accurately estimate the total number of cases.

Methods
Data collection

Two methods of data collection were used for this project: a passive data system whereby data about cases of
FXS and MD statewide were ascertained through the
linkage of multiple administrative data systems and an
active data collection system whereby data about cases
of FXS and MD were abstracted directly from medical
records from medical practices that serve individuals
with the two conditions. The passive system was statewide and the active surveillance was conducted in five
target counties. The data processes were conducted independently without records identified in the passive
system being referred to the active system or vice versa.
Both approaches were conducted by state agencies; the
passive data system was completed by the Health and
Demographics Section of the South Carolina Office of
Revenue and Fiscal Affairs (RFA) and the active data
collection was completed by Maternal and Child Health
Bureau at the South Carolina Department of Health and
Environmental Control (DHEC). DHEC is the state
health department and RFA serves as a central repository
for health and human service data in South Carolina.
The passive data system linked data from the following
sources to identify potential cases of FXS and MD
statewide: uniform billing hospital discharge including
inpatient hospitalizations and emergency department
visits, a private insurer, Medicaid data and a disability
service agency. Data from inpatient admissions and
emergency department visits for all hospitals operating
in South Carolina were included in the uniform billing
hospital discharge data. Every diagnosis code given at
each hospital visit was included in the data analyzed. In
some instances there were over 12 diagnosis codes given
for a single hospital admission, all of which were used in
this study if they indicated MD or FXS. The private
insurer data utilized in this study covered state government employees (including teachers) statewide. The data
from the disability service agency included voluntary
registry data for individuals with FXS or MD who
registered for services. All data with service dates from
1996-2012 were included in this linked passive surveillance dataset. This 17 year surveillance period increases
the likelihood that an individual with FXS or MD will
receive services through one or more of the passive
surveillance data sources, as utilization of these services depends greatly on the severity and progression
of the condition.
We used the International Classification of Diseases,
9th revision, Clinical Modification (ICD-9-CM) code
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759.83 to identify potential FXS and codes 359.0 (congenital hereditary muscular dystrophy), 359.1 (hereditary
progressive muscular dystrophy), and 359.21 (myotonic
muscular dystrophy) to identify potential MD cases from
health claims and an indicator variable from non-health
claims. This passive data linkage process likely resulted
in an overestimate of true number of FXS and MD cases
statewide, since it is possible that suspected cases for
whom confirmatory tests for FXS or MD were ordered
by the physician had negative results. When an individual had only one code for FXS or MD this was most
likely the case.
For the active data collection system, each neurology,
orthopedics, or genetics physician practice located
within the five target counties was sent a letter explaining the surveillance goal of the project, DHEC’s public
health authority to access the medical records, and the
liability protection afforded the practice in the release of
the information by South Carolina state law. Each letter
was followed-up with a call to the practice to determine
whether the practice had current or past patients with
FXS or MD, and, if so, an appointment was made for a
DHEC nurse abstractor to visit the practice to collect
the relevant data on each case. Patients were considered
to be cases in the active data collection system if there
was a positive genetic test or a clear diagnosis as a case
from a physician in one of the included specialties. The
five target counties were in two standard metropolitan
statistical areas (SMSAs).
The actively- and passively-collected data were combined to estimate the number of true cases of FXS and
MD statewide through capture-recapture methodology.
Data usage approvals were obtained from participating
organizations from which the data originated. Data
collection was conducted in accordance to prevailing
ethical principles and approved by the DHEC Institutional Review Board. All data linkages and analyses were
performed at RFA and aggregate results were provided
to investigators. The number of cases presented in this
paper represent unique individuals and not the number
of times a diagnosis code is used. A proprietary unique
identifier generation system is utilized by RFA to identify
individuals in each passive data source to allow for
appropriate individual-level linkage across data sources.
This same unique identifier system was applied to the
active surveillance data to allow for the individual-level
linkage of the active and passively collected data for
this analysis.
Population

The population under study is described with respect to
age, race, and whether care was received in one of the
active surveillance counties in Table 1. Demographic
variables available to describe the population are limited
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to those common to all passive surveillance sources. For
MD and FXS all cases in the active surveillance system
received care in the active surveillance counties by
definition. Among individuals with an MD ICD code
statewide, 43.2% received care in an active surveillance
county. Among individuals with an FXS ICD code statewide, 29.1% received care in an active surveillance
county. For both MD and FXS the age distribution
between the actively collected cases and the passively
collected cases were similar. However, a greater percentage of MD and FXS cases identified in the active data
system had a race other than white or black or did not
have a race indicated in the medical record.
Capture-recapture analysis

Capture-recapture methods were applied to passive data
sources to develop an estimate of the number of cases
for FXS and MD for comparison to numeric estimates
from the active data collection system. The log-linear
estimation method of capture-recapture analysis was
employed to estimate the number of cases of FXS and
MD in South Carolina [16, 17]. Capture-recapture
counts the number of cases that appear in more than
one of the data sources and using this information to
estimate the number of cases that do not appear in any
of the data sources.
Capture-recapture analyses apply probabilistic estimation techniques to multiple incomplete lists of cases to
estimate the number of cases in the underlying population. These methods rely on assessing the number of
individual cases that are identified on more than one list
and assessing the independence of the lists. The technique employed in this analysis (log-linear estimation)
uses log-linear Poisson regression models to account for
dependence by adjusting for the frequency with which
individuals appear on more than one list. These models
are then used to predict the number of unobserved cases.
If three incomplete lists of cases are used, the number
of cases identified only on the first list can be denoted as
Z100. Similarly, the number of cases identified only on
the second list can be denoted as Z010 and the number
of cases identified on both the second and third lists can
be denoted as Z011 and so on. Then, Z000 represents the
number of cases in the population unobserved on any of
the incomplete lists. Each of these observed numbers of
cases appearing on each combination of lists, Zijk , can be
predicted with a log-linear model using information
from the number of cases observed on the other combination of lists using Eq. (1). This results in predicted
values (Ẑ001, Ẑ010, Ẑ100, …) for each observed number
cases. Then, the number of unobserved cases can be estimated based on the estimates from the observed cases
using Eq. (2). This analysis was conducted using SAS 9.4
(SAS Institute, Cary, NC) under the capture-recapture
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Table 1 Demographic characteristics of muscular dystrophy and fragile X syndrome cases reviewed from active and passive
surveillance data sources
Muscular Dystrophy

Fragile X Syndrome

Active n = 384

Passive n = 3305

Active n = 141

Passive n = 795

n

%

n

%

n

%

n

%

0 to 9

26

6.8%

286

8.7%

12

8.5%

80

10.1%

10 to 19

57

14.8%

477

14.4%

35

24.8%

169

21.3%

20 to 29

62

16.1%

389

11.8%

31

22.0%

202

25.4%

30 to 39

59

15.4%

338

10.2%

23

16.3%

114

14.3%

40 to 49

37

9.6%

405

12.3%

12

8.5%

94

11.8%

50 to 59

53

13.8%

483

14.6%

14

9.9%

57

7.2%

60 or older

90

23.4%

927

28.0%

14

9.9%

79

9.9%

White

262

68.2%

1998

60.5%

66

46.8%

433

54.5%

Black (African American)

75

19.5%

805

24.4%

57

40.4%

286

36.0%

Other/Unknown

47

12.2%

97

2.9%

18

12.8%

76

9.6%

384

100.0%

1428

43.2%

141

100.0%

231

29.1%

Demographic Characteristic
Age Group (in years)

Race

Receiving Care in Active Counties

assumption that each data source was indpendent.
Therefore, interaction among the data sources was not
assessed. Additional details about this capture-recapture
methodology can be found elsewhere [16, 17].

logE Z ijk ¼ u þ u1 I ði ¼ 1Þ þ u2 I ðj ¼ 1Þ þ u3 I ðk ¼ 1Þ
þu12 I ði ¼ j ¼ 1Þ þ u13 I ði ¼ k ¼ 1Þ
þ u23 I ðj ¼ k ¼ 1Þ þ u123 I ði ¼ k ¼ k ¼ 1Þ

ð1Þ
Z^ 000 ¼Z^ 001 Z^ 010 Z^ 100 Z^ 11

=^

^ 101 Z
^ 011
Z 110 Z

ð2Þ

One important assumption of capture-recapture
methods is that each data source includes an underestimate of the total population of cases. Since codes are
used for tests performed to both confirm and to rule out
a diagnosis, our sample violates the assumption that the
codes represent an underestimate of the true number of
cases. Therefore, in this study we sought to pare down
the potential FXS or MD cases identified through the
passive system so that they represent a subset of true
cases. We did this using a step-wise approach with the
following algorithm:
1. Start with the total number of cases identified by at
least one ICD-9-CM code in the passive dataset,
2. Restrict to cases with at least one ICD-9-CM code
from a facility located in the five target counties,
3. Restrict to cases with at least one in-patient ICD-9CM code or at least two outpatient ICD-9-CM

codes from a facility located in the five target
counties,
4. Restrict to cases with at least one in-patient ICD-9CM code or at least two outpatient ICD-9-CM
codes in a facility located in the five target counties
where at least one of the diagnoses was made by a
neurologist, geneticist, or developmental
pediatrician.
This algorithm is applied until the analyst is
confident that the number of cases included represents an underestimate of the number of true cases
in the given population. In the present analysis we
compare the number of passively identified cases
present at each step of the algorithm with the number of cases identified using active surveillance, terminating the algorithm when the number of passively
identified cases is less than the number of actively
identified cases. In other situations a complete list of
actively identified cases would likely not be available.
In these instances we recommend using an estimated
number of cases based applying a published prevalence estimate to the population under study. After
this restriction was made and the total number of
cases in the passive system was an underestimate of
the total number of cases in the active system, loglinear estimation capture-recapture methods were applied to estimate the number of cases [18, 19].
The number of cases estimated through the passive
analysis was compared to the number of cases abstracted
through the active data collection system, considering
the active data collection to be the ‘gold-standard’.
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Results
There were 384 MD cases confirmed using active surveillance among practices located in the five target counties. Additionally, there were 1,683 records identified as
potential MD cases by the practices that were abstracted,
but determined to not be true cases upon clinical review.
There were 141 FXS cases confirmed using active
surveillance among practices located in the five target
counties and 72 additional records were abstracted but
determined to not be cases.
From the passive system, the number of sources on
which each MD and FXS case is found is displayed in
Table 2. We are unable to publicly identify the number
of cases identified by each combination of sources due
to the restrictions outlined in the data use agreement
with RFA that provides access to the passive data. The
number of potential cases identified at each step of the
passive data restriction algorithm is presented in Table 3.
For MD, the passive dataset does not produce a lower
number of cases than the number identified in the active
dataset until step 4 in the data restriction algorithm
(passive n = 375, active n = 384). For FXS, the passive
dataset does not produce a lower number of cases than
the number identified in the active dataset until step 3
(passive n = 134, active n = 141).
When capture-recapture analysis is applied to the passively collected estimate for the number of MD cases
achieved at step 4 of the data restriction algorithm, an
additional group of 40 cases is estimated. This results in
a total of 415 MD cases estimated through applying a
capture-recapture process to the passively collected data,
compared to 384 cases that were collected through active surveillance in the same geographic area (Table 4).
Similarly for FXS, Table 4 shows that an additional six
cases were estimated through capture-recapture analysis
of the passively collected estimated number of cases
after applying the data restriction algorithm. This results
in a total of 140 estimated FXS cases through passive
data collection supplemented by capture-recapture analysis, compared to 141 cases collected through active
surveillance.
Table 2 Number of data sources on which each passively
identified muscular dystrophy and fragile X syndrome case
is found
# of Sources
Muscular Dystrophy

Fragile X Syndrome

n

%

1

2275

68.8%

2

872

26.4%

3 or more

158

4.8%

1

586

73.7%

2

147

18.5%

3 or more

62

7.8%

After linking the 384 actively collected MD cases and
141 actively collected FXS cases to their respective passive datasets, we found that, despite the fact that the estimated total numbers of cases were reasonably similar
to the numbers estimated using capture-recapture analysis, the cases used to develop the estimates did not
correspond for the most part to the cases identified
through active surveillance. That is, most of the actively
identified cases were not identified by the passive system, producing a sensitivity of 20.1% and 39.7% for MD
and FXS, respectively (Table 5).
As might be expected, the passive system performed
better when identifying non-cases in the active system,
with specificities of 96.5% for MD and 75.7% for FXS.
The positive predictive values for cases identified in the
passive system were 56.6% for MD and 75.7% for FXS.

Discussion
Active surveillance through medical record abstraction
is time consuming and costly. Passive surveillance for
rare conditions that are identified simply searching for
diagnosis codes can lead to over-documentation in
claims databases. This over-documentation may lead to
an overestimation of cases for rare conditions and troubling implications for health services research. The objective of this project was to refine the numeric
estimates of two rare conditions by applying capturerecapture methodology to passively collected data.
A primary obstacle for applying capture-recapture
methods to passively collected data is that these
methods assume that multiple sources each have incomplete data on the number of true cases. In reality, with
most claims data sources the number of cases may be
overestimated because diagnostic coding is applied to
both confirm or to rule out a diagnosis, through misdiagnosis, and when a condition is suspected but unconfirmed. In this study, the cases identified through active
medical record abstraction were used as the true number of cases. To get a better estimate from the passive
system we proposed first restricting to cases with at least
one in-patient diagnostic code or two outpatient diagnostic codes and then, if necessary, restricting to diagnoses made by specialists, who are most likely to diagnose
true cases.
It should be noted that this study focused on individuals receiving care for FXS or MD in the five county
geographic area covered by active data collection. It is
probably equally important to estimate the true cases by
county of residence, using active and passive datasets,
however, doing so would require using a subset of the
cases collected by the active surveillance system (restricted to individuals residing in the five county area).
Applying this data restriction algorithm successfully
led to underestimates for both MD and FXS. After this
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Table 3 Number of cases identified in active and passive surveillance systems at each step of the passive data restriction algorithm
Passive Data Restriction Algorithm Step

Muscular Dystrophy

Fragile X Syndrome

Cases
Identified Active

Cases
Identified Active

Cases
Identified Passive

Cases
Identified Passive

1. Cases with at least one ICD-9-CM code

384

3,305

141

795

2. Cases with at least one ICD-9-CM code given in a facility in target counties

384

1,428

141

231

3. Cases with at least one in-patient ICD-9-CM code or at least two outpatient
ICD-9-CM codes given in a facility in target counties

384

990

141

134a

4. Cases with at least one in-patient ICD-9-CM code or at least two outpatient
ICD-9-CM codes given in a facility in target counties where at least one of the
diagnoses was made by a neurologist, geneticist, or developmental pediatrician

384

375a

141

50

a

Indicates the step at which the number of cases identified through the passive system is an underestimate of the cases identified through the active system

restriction was made, applying capture-recapture analysis resulted in a slight overestimate of the number of
MD cases and a very close estimate to the number of
FXS cases collected through active surveillance. These
estimated numbers of cases seem to be reasonable and
indicate that restricting passively collected data and then
applying a capture-recapture approach would be much
more efficient than conducting active data collection to
arrive at these figures.
Of course, in practice an actively collected dataset
would likely not be available to apply the data restriction
algorithm against, as having an actively collected surveillance data would eliminate the need for linking passive
datasets for obtaining an estimated number of cases. In
this case, we recommend using prevalence estimates
from relevant literature to provide a reasonable number
of cases to use in applying the data restriction algorithm.
This will allow for the use of the best available prevalence estimates from the literature, with local data adding additional context and information to provide an
improved case volume estimate. In the absence of actively collected data, which again would likely be the
case in application, combining the capture-recapture estimate and the most appropriate prevalence estimate

from relevant literature may provide a suitable range for
true cases in an area.
Upon linking the actively collected data to the passively collected data we found that there was little concordance between the actively identified cases and the
passively identified cases. This lack of concordance between the active data system and the cases used in the
passive capture-recapture estimate is not unexpected.
The purpose of applying a capture-recapture algorithm
is to estimate the correct number of cases and not to
identify “true” cases. The lack of concordance between
the actively identified cases and the passively identified
cases serves to illustrate that assuming that cases identified through passively collected administrative data using
the methods presented in this paper should not be assumed to be “true” cases. A different methodology for
identifying a subset of cases from passively collected administrative data that are likely to be “true” cases has
been developed and presented elsewhere [20]. Furthermore, a majority of the cases identified in the active surveillance system were also identified in the passive
surveillance system (68.2% of actively identified MD
cases were found in the passive data system and 69.5%
of actively identified FXS cases were found in the passive

Table 4 Results of capture-recapture analysis to estimate the total number of true cases using only passive data
Muscular Dystrophy
Population

Cases with at least one in-patient ICD-9-CM code or at least two
outpatient ICD-9-CM codes given in a facility in target counties
where at least one of the diagnoses was made by a neurologist,
geneticist, or developmental pediatrician

Cases in
Passive
Dataset

Additional Cases
Estimated by CaptureRecapture

Total Estimated
Cases from
Passive Data

Total Cases
Observed in
Active Data

375

40

415

384

Cases in
Passive
Dataset

Additional Cases
Estimated 2by CaptureRecapture

Total Estimated
Cases from
Passive Data

Total Cases
Observed in
Active Data

134

6

140

141

Fragile X Syndrome
Population

Cases with at least one in-patient ICD-9-CM code or at least two
outpatient ICD-9-CM codes given in a facility in target counties

Smith et al. Orphanet Journal of Rare Diseases (2017) 12:76

Page 7 of 8

Table 5 Sensitivity, Specificity, and Positive Predictive Value of passive dataset after linking to active dataset
Population

Sensitivity

Specificity

Positive Predictive Value

20.1%

96.5%

56.6%

39.7%

75.0%

75.7%

Muscular Dystrophy
Cases with at least one in-patient ICD-9-CM code or at least two outpatient ICD-9-CM codes
given in a facility in target counties where at least one of the diagnoses was made by a
neurologist, geneticist, or developmental pediatrician
Fragile X Syndrome
Cases with at least one in-patient ICD-9-CM code or at least two outpatient ICD-9-CM codes
given in a facility in target counties

system), but many of these cases were among those that
were dropped when the data restriction algorithm was
applied. This was considered to be an acceptable tradeoff because the intent of this analysis was to estimate
the number of cases in the five-county area and not to
identify a subset of passively identified cases that are
“true” cases.
It is reasonable to expect that a number of cases
could be identified in the active data surveillance system but not be present in the passive data system.
For example, there could be a substantial number of
MD and FXS cases covered by private insurance
through a non-state government employer that have
manifested in childhood and received a diagnosis in a
neurology office but do not have symptoms severe
enough to result in hospitalization or utilization of
disability agency services. Similarly, it may not be appropriate to assume that “cases” meeting the strict
definition used for passive surveillance in our study
but not found by active surveillance are in fact “false
positives.” Some of these cases may in fact be true
cases that were not treated in the practices reviewed;
for example, individuals may travel outside the target
counties to receive specialty care related to their condition, or they may lack adequate health insurance
coverage and therefore receive their health care in
hospital emergency departments or other settings not
included in our active surveillance approach [21].
Muscular dystrophy may be an especially difficult set
of conditions to correctly identify through passive data
collection. As described in Table 3, there were 3,305 potential cases of MD identified through the ICD-9 CM
codes specific to MD, while only 384 cases were identified through active data collection. The ICD-9 CM used
for MD diagnoses also capture other, related neuromuscular conditions. Therefore, for rare conditions like MD
with a clinically complex phenotype and non-specific
billing codes, true case identification through passively
collected administrative data sources may be less feasible
than for other conditions with more specific clinical
markers and well-defined billing codes.
Finally, it should be stressed that our choice of criteria
for identifying cases in the passive surveillance was not
based solely on the desire to maximize sensitivity,

specificity and positive predictive value but stipulated
that the resulting cases would underestimate the true
prevalence. It may be that other case definitions would
be preferable to optimize the accuracy of passive data
for identifying cases. Identifying these case definitions
should be considered in future research.

Conclusions
In conclusion, the findings of this study suggest that
capture-recapture methods may be useful for the purposes of estimating the number of cases of rare conditions in a defined population where administrative data
are available, but active data collection is unfeasible. This
approach would require beginning with a reasonable estimate of the number of cases for the target population,
perhaps based on prevalence estimates from the literature adjusted for the demographic characteristics of the
target population. The capture-recapture method provides a framework that will help researchers using big
data learn how to improve their estimates.
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